Prostatitis is the inflammation of the prostate that may be caused by infection, chronic pelvic pain syndrome or asymptomatic prostate inflammation.
Prominent features are genitourinary, pelvic or rectal pain and lower urinary tract symptoms, eg urinary frequency, urgency, hesitancy, weak stream and straining on urination, dysuria, pain that increased with urination.
A spectrum of disorders that affect men whose symptoms are referable to the lower urogenital tract & perineum
Etiologic agents are the same for both acute bacterial prostatitis (ABP) & chronic bacterial prostatitis (CBP) & include E coli (most commonly isolated pathogen), Enterococcus sp, Klebsiella sp, Proteus sp, P aeruginosa, C trachomatis, U urealyticum, T vaginalis
Immune-deficient or human immunodeficiency virus (HIV) patients may have pathogens such as S typhi, M avium, M tuberculosis, Candida sp, C immitis, B dermatitidis, H capsulatum
Signs and Symptoms
Prominent features are genitourinary, pelvic or rectal pain & lower urinary tract symptoms, eg urinary frequency, urgency, hesitancy, weak stream & straining on urination, dysuria, pain that increased w/ urination
The novel coronavirus disease (COVID-19) pandemic appears to have a significant impact on oncological care, according to a study, which stresses the need for psycho-oncological support for cancer patients.
Ensituximab, a chimeric monoclonal antibody targeting a variant of MUC5AC, shows modest clinical activity with good safety profile in patients with refractory colorectal cancer, according to data from a phase II study.